Pharmacological and clinical profile of imidafenacin developed as a new therapeutic agent for overactive bladder

Folia Pharmacologica Japonica

Volumn 131, Issue 5, 2008, Pages 379-387

  Uno, Takashi ^a   Kobayashi, Fumiyoshi ^a   Ogata, Akihito ^a   Konomi, Toshihiko ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAFENACIN; METHYLSCOPOLAMINE;

CLINICAL PHARMACOLOGY; HUMAN; LOWER URINARY TRACT SYMPTOM; MICTURITION; OVERACTIVE BLADDER; POST MICTURITION SYMPTOM; QUALITY OF LIFE; REVIEW; STORAGE SYMPTOM; SYMPTOMATOLOGY; VOIDING SYMPTOM;

ACETYLCHOLINE; ANIMALS; CARBACHOL; CLINICAL TRIALS AS TOPIC; DRUG TOXICITY; ELECTRIC STIMULATION; HUMANS; IMIDAZOLES; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; QUALITY OF LIFE; RECEPTORS, MUSCARINIC; URINARY BLADDER; URINARY BLADDER, OVERACTIVE; URINATION;

EID: 46849089900     PISSN: 00155691     EISSN: 13478397     Source Type: Journal    
DOI: 10.1254/fpj.131.379     Document Type: Review

References (20)

1. Japanese source
2. Japanese source
3. Andersson K-E. Lancet Neurol. 2004;3:46-53.
4. Goyal RK. N Engl J Med. 1989;321:1022-1029.
5. Eglen RM, et al. Pharmacol Toxicol. 1996;78:59-68.
6. Matsui M, et al. Proc Natl Acad Sci USA. 2000;97:9579-9584.
7. Nelson CP, et al. J Pharmacol Exp Ther. 2004;310:1255-1265.
8. Somogyi GT, et al. J Auton Nerv Sys. 1992;37:89-98.
9. Braverman AS, et al. Am J Physiol. 1998;274:R517-R523.
10. Kobayashi F, et al. Arzneim Forsch Drug Res. 2007;57:92-100.
11. Murakami S, et al. Urol Int. 2003;71:290-298.
12. Kobayashi F, et al. Arzneim Forsch Drug Res. 2007;57:147-154.
13. Andersson K-E. Urology Suppl. 2002;1:23-28.
14. Japanese source
15. Japanese source
16. Japanese source
17. Japanese source
18. Japanese source
19. Japanese source
20. Japanese source